UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 252

Sortiert nach

CXCR4-targeted theranostics in oncology

European journal of nuclear medicine and molecular imaging, 2022-10, Vol.49 (12), p.4133-4144

2022

Volltextzugriff (PDF)

Radioligands Targeting Fibroblast Activation Protein (FAP)

Cancers, 2021-11, Vol.13 (22), p.5744

2021

Volltextzugriff (PDF)

Lymphoma-Sink Effect in Marginal Zone Lymphoma Based on CXCR4-Targeted Molecular Imaging

Molecular imaging and biology, 2023-08, Vol.25 (4), p.758-764

2023

Volltextzugriff (PDF)

Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4-Directed Molecular Imaging and Therapy

Clinical nuclear medicine, 2023-06, Vol.48 (6), p.483

2023

Volltextzugriff (PDF)

Associations between Normal Organs and Tumor Burden in Patients Imaged with Fibroblast Activation Protein Inhibitor-Directed Positron Emission Tomography

Cancers, 2022-05, Vol.14 (11), p.2609

2022

Volltextzugriff (PDF)

Development of Discordant Hypermetabolic Prostate Cancer Lesions in the Course of [177Lu]PSMA Radioligand Therapy and Their Possible Influence on Patient Outcome

Cancers, 2021-09, Vol.13 (17), p.4270

2021

Volltextzugriff (PDF)

Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced Readers

Molecular imaging and biology, 2022-08, Vol.24 (4), p.631-640

2022

Volltextzugriff (PDF)

Predicting Microenvironment in CXCR4- and FAP-Positive Solid Tumors-A Pan-Cancer Machine Learning Workflow for Theranostic Target Structures

Cancers, 2023-01, Vol.15 (2), p.392

2023

Volltextzugriff (PDF)

Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT

Cancers, 2022-01, Vol.14 (2), p.270

2022

Volltextzugriff (PDF)

In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic Target

Cancers, 2023-07, Vol.15 (14), p.3595

2023

Volltextzugriff (PDF)

High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL

Molecular imaging, 2022-02, Vol.2022, p.7056983-7056983

2022

Volltextzugriff (PDF)

CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas

Diagnostics (Basel), 2021-03, Vol.11 (4), p.605

2021

Volltextzugriff (PDF)

Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using 68Ga-Pentixafor PET

The Journal of nuclear medicine (1978), 2022-11, Vol.63 (11), p.1687-1692

2022

Volltextzugriff (PDF)

Theranostics in Hematooncology

Journal of Nuclear Medicine, 2023-07, Vol.64 (7), p.1009-1016

2023

Volltextzugriff (PDF)

PSMA PET/CT for Response Assessment of 177Lu-PSMA Therapy

Seminars in nuclear medicine, 2024-01, Vol.54 (1), p.69-76

2024

Volltextzugriff (PDF)

Altered NFATc1 activity blocks T cell development and facilitates the pathogenesis of T-acute lymphoblastic leukemia

European journal of cancer (1990), 2016-07, Vol.61, p.S176-S176

2016

Volltextzugriff (PDF)

Prostate-specific Membrane Antigen Reporting and Data System Version 2.0

European urology, 2023-11, Vol.84 (5), p.491-502

2023

Volltextzugriff (PDF)

FAPI-PET in Cardiovascular Disease

Seminars in nuclear medicine, 2024-03, Vol.54 (5), p.747-752

2024

Volltextzugriff (PDF)

Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma

European journal of nuclear medicine and molecular imaging, 2024-06

2024

Volltextzugriff (PDF)

C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma

Journal of Nuclear Medicine, 2023-01, Vol.64 (1), p.34-39

2023

Volltextzugriff (PDF)

Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up

European journal of nuclear medicine and molecular imaging, 2022-10, Vol.49 (12), p.4262-4270

2022

Volltextzugriff (PDF)

Red Bull PET/CT

Nuklearmedizin. Nuclear medicine, 2024-04, Vol.63 (2), p.76

2024

Volltextzugriff (PDF)

Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinoma

European journal of nuclear medicine and molecular imaging, 2023-05, Vol.50 (6), p.1833-1834

2023

Volltextzugriff (PDF)

Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors

European journal of nuclear medicine and molecular imaging, 2023-08, Vol.50 (10), p.3011-3021

2023

Volltextzugriff (PDF)

Pitfalls in PSMA-PET/CT: intensive bone marrow uptake in a case with polycythemia vera

European journal of nuclear medicine and molecular imaging, 2021-05, Vol.48 (5), p.1669-1670

2021

Volltextzugriff (PDF)

1 – 25 von 252

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(222)
Mit Volltextzugriff
(214)

Publikationsform

Sprache

Englisch
(239)
Japanisch
(19)
Deutsch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(156)
Life Sciences & Biomedicine
(143)
Humans
(95)
Animals
(70)
Mice
(46)
Radiology, Nuclear Medicine & Medical Imaging
(38)
Immunology
(36)
Biochemistry & Molecular Biology
(33)
Base Sequence
(29)
Biological And Medical Sciences
(23)
Molecular Sequence Data
(23)
Oncology
(22)
Medicine
(21)
Medicine & Public Health
(21)
Nfatc Transcription Factors
(21)
Tumors
(20)
Interleukin-2 - Genetics
(19)
Transcription Factors - Genetics
(19)
Male
(18)
Theranostics
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

CXCR4-targeted theranostics in oncology

Radioligands Targeting Fibroblast Activation Protein (FAP)

Lymphoma-Sink Effect in Marginal Zone Lymphoma Based on CXCR4-Targeted Molecular Imaging

Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4-Directed Molecular Imaging and Therapy

Associations between Normal Organs and Tumor Burden in Patients Imaged with Fibroblast Activation Protein Inhibitor-Directed Positron Emission Tomography

Development of Discordant Hypermetabolic Prostate Cancer Lesions in the Course of [177Lu]PSMA Radioligand Therapy and Their Possible Influence on Patient Outcome

Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced Readers

Predicting Microenvironment in CXCR4- and FAP-Positive Solid Tumors-A Pan-Cancer Machine Learning Workflow for Theranostic Target Structures

Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT

In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic Target

High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL

CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas

Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using 68Ga-Pentixafor PET

Theranostics in Hematooncology

PSMA PET/CT for Response Assessment of 177Lu-PSMA Therapy

Altered NFATc1 activity blocks T cell development and facilitates the pathogenesis of T-acute lymphoblastic leukemia

Prostate-specific Membrane Antigen Reporting and Data System Version 2.0

FAPI-PET in Cardiovascular Disease

Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma

C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma

Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up

Red Bull PET/CT

Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinoma

Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors

Pitfalls in PSMA-PET/CT: intensive bone marrow uptake in a case with polycythemia vera

Suchergebnisse filtern